Mitsubishi UFJ Trust & Banking
WST icon

Mitsubishi UFJ Trust & Banking’s West Pharmaceutical WST Stock Holding History

Mitsubishi UFJ Trust & Banking’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.5M Buy
34,853
+779
+2% +$238K 0.03% 458
2026
Q1 		$8.54M Sell
34,074
-433
-1% -$108K 0.02% 534
2025
Q4 		$9.49M Sell
34,507
-58
-0.2% -$15.9K 0.02% 529
2025
Q3 		$9.07M Sell
34,565
-1,943
-5% -$472K 0.02% 573
2025
Q2 		$7.99M Sell
36,508
-1,559
-4% -$333K 0.02% 605
2025
Q1 		$8.52M Sell
38,067
-797
-2% -$220K 0.02% 574
2024
Q4 		$12.7M Sell
38,864
-1,426
-4% -$449K 0.03% 514
2024
Q3 		$12.1M Sell
40,290
-8,581
-18% -$2.63M 0.03% 542
2024
Q2 		$16.1M Buy
48,871
+3,855
+9% +$1.36M 0.04% 432
2024
Q1 		$17.8M Sell
45,016
-3,395
-7% -$1.26M 0.04% 417
2023
Q4 		$17M Sell
48,411
-3,248
-6% -$1.15M 0.04% 431
2023
Q3 		$19.4M Sell
51,659
-911
-2% -$352K 0.05% 383
2023
Q2 		$20.1M Buy
52,570
+2,003
+4% +$716K 0.05% 389
2023
Q1 		$17.5M Sell
50,567
-797
-2% -$233K 0.04% 418
2022
Q4 		$12.1M Sell
51,364
-6,173
-11% -$1.46M 0.03% 503
2022
Q3 		$14.2M Sell
57,537
-3,260
-5% -$993K 0.04% 436
2022
Q2 		$18.4M Sell
60,797
-2,000
-3% -$651K 0.05% 394
2022
Q1 		$25.8M Sell
62,797
-2,830
-4% -$1.11M 0.06% 334
2021
Q4 		$30.8M Sell
65,627
-2,967
-4% -$1.28M 0.06% 317
2021
Q3 		$29.1M Sell
68,594
-5,631
-8% -$2.37M 0.06% 325
2021
Q2 		$26.7M Buy
74,225
+15,166
+26% +$5.01M 0.06% 360
2021
Q1 		$16.6M Sell
59,059
-14,024
-19% -$4.01M 0.04% 476
2020
Q4 		$20.7M Buy
73,083
+8,629
+13% +$2.42M 0.04% 438
2020
Q3 		$17.7M Sell
64,454
-1,119
-2% -$296K 0.04% 428
2020
Q2 		$14.9M Buy
65,573
+2,777
+4% +$546K 0.04% 448
2020
Q1 		$9.56M Buy
62,796
+10,905
+21% +$1.68M 0.03% 496
2019
Q4 		$7.8M Buy
+51,891
New +$7.56M 0.02% 655

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Mitsubishi UFJ Trust & Banking's WST Position: Q2 2026 in Review

Mitsubishi UFJ Trust & Banking increased its West Pharmaceutical (WST) stake by 2.3% in Q2 2026, buying an estimated $238K and bringing the position to 34,853 shares worth $12.5M. The position accounts for 0.03% of the portfolio, ranked #458.

Mitsubishi UFJ Trust & Banking first reported a position in WST in Q4 2019 and has held it in 27 quarters since. The position peaked at $30.8M in Q4 2021. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Mitsubishi UFJ Trust & Banking held 34,853 shares of West Pharmaceutical worth $12.5M as of Q2 2026.
  • Mitsubishi UFJ Trust & Banking bought 779 West Pharmaceutical shares in Q2 2026, an estimated $238K.
  • West Pharmaceutical made up 0.03% of Mitsubishi UFJ Trust & Banking's portfolio in Q2 2026, its #458 holding.
  • Mitsubishi UFJ Trust & Banking first reported a position in West Pharmaceutical in Q4 2019 and has held it in 27 quarters since.
  • Mitsubishi UFJ Trust & Banking's West Pharmaceutical position peaked at $30.8M in Q4 2021.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q2 2026, filed 6 Aug 2026.